Families are feeling stressed, powerless and ‘forever in limbo’ as they wait months, or sometimes years, for Attention-Deficit Hyperactivity Disorder (ADHD) assessments, according to a new study. Research led by the University of Southampton and King’s College London examined […]
Home testing kits that screen for cervical cancer risk could be a game-changer for reducing health inequalities for physically Disabled women, according to a new University of Sheffield […]
People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and […]
A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health finds that out-of-pockets caps on insulin for Medicare Part D beneficiaries have reined […]
Nearly 1 in 2 Americans has high blood pressure—sometimes called the “silent killer” because it harms the heart and blood vessels—but many people don’t know they have it. […]
Fake news can be tricky to spot, but spotting fake drugs just got a little easier. Researchers have devised a low-cost way to help distinguish legitimate medications from […]
The latest, most comprehensive data on the scale of drink spiking in the UK will be presented to the public for the first time at Anglia Ruskin University […]
A new University of Missouri study suggests mental health policies can play a significant role in how Americans choose political candidates. Past scholarly research has found that most […]
A one-size-fits-all approach to prediabetes treatment may miss the opportunity to implement an early, more intensive, tailored prevention approach for those with the highest risk of developing Type […]
People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get […]
In a clinical trial supported by the National Institutes of Health (NIH), a research team found that administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder […]
A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range of mental health conditions – found no evidence that medicinal cannabis is […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.
